Medicine and Dentistry

1. Adverse Event 14%
2. Aflibercept 5%
3. Age 5%
4. Age Related Macular Degeneration 25%
5. Analysis 10%
6. Angiogenesis Inhibitor 5%
7. Best Corrected Visual Acuity 20%
8. Brachytherapy 50%
9. Controlled Clinical Trial 25%
10. Diabetes Mellitus 25%
11. Drug 5%
12. Drug Delivery System 5%
13. Follow up 5%
14. Hospital 6%
15. Injection 65%
16. Intention-to-Treat Analysis 8%
17. Intravitreal Administration 11%
18. Lesion 12%
19. Macular Hole 25%
20. Monotherapy 7%
21. Morphology 5%
22. Ocriplasmin 37%
23. Optical Coherence Tomography 5%
24. Pars Plana Vitrectomy 24%
25. Patient 41%
26. Quality of Life 5%
27. Radiation Retinopathy 5%
28. Randomized Clinical Trial 25%
29. Randomized Controlled Trial 36%
30. Retinal Detachment 6%
31. Retreatment 5%
32. Stereotactic Radiotherapy 50%
33. Student T Test 5%
34. Systematic Review 6%
35. Therapeutic Procedure 41%
36. Vasculotropin 23%
37. Visual Acuity 37%
38. Visual Impairment 6%
39. Vitrectomy 26%
40. Vitreous 6%
41. Vitreous Hemorrhage 25%
42. Wet Macular Degeneration 100%